Home › Liposarcoma › New Jersey
Liposarcoma clinical trials in New Jersey
5 studies for Liposarcoma are looking for participants at sites in New Jersey.
Cities in New Jersey
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Nov 12, 2026 · NCT06541262Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Bergen, Montvale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06422806Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Cooper Hospital University Medical Center, Camden
- HMH-Hackensack University Medical Center, Hackensack
- Jersey Shore University Medical Center, Neptune City
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT04031677A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06843967A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT07089992From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.